8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Mar 18, 2026·SEC
Material company update
Jan 8, 2026·SEC
Sera Prognostics, Inc.(SERA)Earnings, Financials & Key Ratios
SERA•NASDAQ
$1.92
$73M mkt cap·Price updated May 7, 2026
AboutSera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.Show more
- Revenue$81K+5.2%
- EBITDA-$36M+0.7%
- Net Income-$32M+2.9%
- EPS (Diluted)-0.67+32.3%
- Gross Margin-102.47%-1478.0%
- EBITDA Margin-43906.17%+5.6%
- Operating Margin-45066.67%+5.3%
- Net Margin-39417.28%+7.7%
- ROE-51.83%+7.1%
- ROIC-46.25%+5.1%
- Debt/Equity0.03+76.5%
- Interest Coverage-4056.00-245.5%
SERA Key Insights
Sera Prognostics, Inc. (SERA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 26.5%
- ✓Trading at only 1.2x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 12 (bottom 12%)
- ✗Shares diluted 43.7% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SERA Price & Volume
Sera Prognostics, Inc. (SERA) stock price & volume — 10-year historical chart
Loading chart...
SERA Growth Metrics
Sera Prognostics, Inc. (SERA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years26.51%
3 Years-32.89%
TTM-50.43%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM2.57%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM30.85%
Return on Capital
10 Years-74.5%
5 Years-50.82%
3 Years-55.39%
Last Year-58.15%
SERA Recent Earnings
Sera Prognostics, Inc. (SERA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 6, 2026EPS
$0.17
Est $0.16
-6.3%
Revenue
$14,000
Est $66,667
-79.0%
Q2 2026
Mar 18, 2026EPS
$0.16
Est $0.17
+5.9%
Revenue
$10,000
Est $31,767
-68.5%
Q4 2025
Nov 13, 2025EPS
$0.16
Est $0.19
+15.8%
Revenue
$16,000
Est $50,350
-68.2%
Q3 2025
Aug 6, 2025EPS
$0.16
Est $0.21
+23.8%
Revenue
$17,000
Est $150,000
-88.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.17vs $0.16-6.3% | $14,000vs $66,667-79.0% |
| Q2 2026 | Mar 18, 2026 | $0.16vs $0.17+5.9% | $10,000vs $31,767-68.5% |
| Q4 2025 | Nov 13, 2025 | $0.16vs $0.19+15.8% | $16,000vs $50,350-68.2% |
| Q3 2025 | Aug 6, 2025 | $0.16vs $0.21+23.8% | $17,000vs $150,000-88.7% |
Based on last 12 quarters of dataView full earnings history →
SERA Peer Comparison
Sera Prognostics, Inc. (SERA) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NTRA | 31.16B | 219.82 | -144.62 | 35.9% | -9.03% | -15.28% | 0.13 | |
 PGNY | 1.57B | 19.16 | 29.48 | 10.4% | 5.23% | 13.34% | 0.05 | |
 OVID | 355.4M | 2.73 | -11.38 | 11.81% | -240.11% | -23.98% | 0.01 | |
 INVA | 1.93B | 22.80 | 6.91 | 18.52% | 118.91% | 46.47% | 0.23 | |
 ILMN | 21.07B | 138.71 | 25.45 | -0.78% | 19.43% | 32.84% | 0.94 | |
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 CSTL | 582.89M | 19.24 | -23.18 | 3.66% | -3.77% | -2.77% | 0.08 | |
 LH | 21.24B | 258.04 | 24.67 | 7.25% | 6.66% | 10.89% | 0.83 |
Compare SERA vs Peers
Sera Prognostics, Inc. (SERA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SERA Income Statement
Sera Prognostics, Inc. (SERA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 36K | 25K | 82K | 268K | 306K | 77K | 81K | 57K |
| Revenue Growth % | - | -30.56% | 228% | 226.83% | 14.18% | -74.84% | 5.19% | -50.43% |
| Cost of Goods Sold | 18K | 11K | 37K | 193K | 210K | 82K | 164K | 166K |
| COGS % of Revenue | 50% | 44% | 45.12% | 72.01% | 68.63% | 106.49% | 202.47% | - |
| Gross Profit | 18K▲ 0% | 14K▼ 22.2% | 45K▲ 221.4% | 75K▲ 66.7% | 96K▲ 28.0% | -5K▼ 105.2% | -83K▼ 1560.0% | -109K▲ 0% |
| Gross Margin % | 50% | 56% | 54.88% | 27.99% | 31.37% | -6.49% | -102.47% | -191.23% |
| Gross Profit Growth % | - | -22.22% | 221.43% | 66.67% | 28% | -105.21% | -1560% | - |
| Operating Expenses | 16.59M | 17.98M | 35.44M | 45.73M | 39.92M | 36.63M | 36.42M | 36.51M |
| OpEx % of Revenue | 46094.44% | 71940% | 43219.51% | 17062.31% | 13044.77% | 47571.43% | 44964.2% | - |
| Selling, General & Admin | 7.24M | 10.2M | 24.42M | 31.48M | 24.69M | 21.9M | 23.25M | 23.64M |
| SG&A % of Revenue | 20113.89% | 40812% | 29781.71% | 11747.39% | 8069.28% | 28441.56% | 28703.7% | - |
| Research & Development | 9.35M | 7.78M | 11.02M | 14.24M | 15.22M | 14.73M | 13.17M | 12.87M |
| R&D % of Revenue | 25980.56% | 31128% | 13437.8% | 5314.93% | 4975.49% | 19129.87% | 16260.49% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.58M▲ 0% | -17.97M▼ 8.4% | -35.4M▼ 97.0% | -45.65M▼ 29.0% | -39.82M▲ 12.8% | -36.63M▲ 8.0% | -36.5M▲ 0.4% | -36.61M▲ 0% |
| Operating Margin % | -46044.44% | -71884% | -43164.63% | -17034.33% | -13013.4% | -47577.92% | -45066.67% | -64235.09% |
| Operating Income Growth % | - | -8.42% | -96.96% | -28.98% | 12.77% | 8% | 0.36% | - |
| EBITDA | -15.63M | -17.08M | -34.74M | -44.9M | -38.92M | -35.8M | -35.56M | -35.89M |
| EBITDA Margin % | -43416.67% | -68304% | -42360.98% | -16752.24% | -12719.28% | -46496.1% | -43906.17% | -62964.91% |
| EBITDA Growth % | - | -9.25% | -103.42% | -29.25% | 13.31% | 8.01% | 0.66% | 0.17% |
| D&A (Non-Cash Add-back) | 946K | 895K | 659K | 756K | 900K | 833K | 940K | 724K |
| EBIT | -14.55M | -18.01M | -34.26M | -44.13M | -36.19M | -32.87M | -36.5M | -37.68M |
| Net Interest Income | -1.91M | -1.8M | -601K | 395K | 1.58M | 2.72M | 4.58M | 2.35M |
| Interest Income | 64K | 42K | 145K | 456K | 1.64M | 2.75M | 4.58M | 2.35M |
| Interest Expense | 1.97M | 1.84M | 746K | 61K | 55K | 28K | 9K | 3K |
| Other Income/Expense | 55K | -1.88M | 386K | 1.47M | 3.58M | 3.74M | 4.58M | 4.47M |
| Pretax Income | -16.52M▲ 0% | -19.85M▼ 20.1% | -35.01M▼ 76.4% | -44.19M▼ 26.2% | -36.24M▲ 18.0% | -32.9M▲ 9.2% | -31.93M▲ 2.9% | -32.14M▲ 0% |
| Pretax Margin % | -45891.67% | -79392% | -42693.9% | -16487.31% | -11843.79% | -42724.68% | -39417.28% | -56385.96% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -16.52M▲ 0% | -19.85M▼ 20.1% | -35.01M▼ 76.4% | -44.19M▼ 26.2% | -36.24M▲ 18.0% | -32.9M▲ 9.2% | -31.93M▲ 2.9% | -32.14M▲ 0% |
| Net Margin % | -45891.67% | -79392% | -42693.9% | -16487.31% | -11843.79% | -42724.68% | -39417.28% | -56385.96% |
| Net Income Growth % | - | -20.14% | -76.39% | -26.21% | 17.98% | 9.23% | 2.95% | 2.57% |
| Net Income (Continuing) | -16.52M | -19.85M | -35.01M | -44.19M | -36.24M | -32.9M | -31.93M | -32.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.13▲ 0% | -1.19▼ 5.3% | -1.18▲ 0.8% | -1.43▼ 21.2% | -1.16▲ 18.9% | -0.99▲ 14.7% | -0.67▲ 32.3% | -0.64▲ 0% |
| EPS Growth % | - | -5.31% | 0.84% | -21.19% | 18.88% | 14.66% | 32.32% | 30.85% |
| EPS (Basic) | -1.13 | -1.19 | -1.18 | -1.43 | -1.16 | -0.99 | -0.67 | - |
| Diluted Shares Outstanding | 18.11M | 18.11M | 30.77M | 30.94M | 31.2M | 33.16M | 47.66M | 50.26M |
| Basic Shares Outstanding | 18.11M | 18.11M | 30.77M | 30.94M | 31.2M | 33.16M | 47.66M | 50.26M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
SERA Balance Sheet
Sera Prognostics, Inc. (SERA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 21.55M | 13.73M | 110.25M | 90.13M | 61.34M | 47.6M | 40.77M | 49.73M |
| Cash & Short-Term Investments | 21.39M | 13.53M | 105.11M | 82.7M | 49.08M | 46.24M | 39.2M | 47.4M |
| Cash Only | 21.39M | 13.53M | 58.93M | 29.88M | 3.88M | 4.04M | 3.94M | 4.17M |
| Short-Term Investments | 0 | 0 | 46.18M | 52.83M | 45.2M | 42.19M | 35.26M | 43.23M |
| Accounts Receivable | 1K | 2K | 3.14M | 6.11M | 11.47M | 34K | 12K | 11K |
| Days Sales Outstanding | 10.14 | 29.2 | 13.99K | 8.33K | 13.68K | 161.17 | 54.07 | 86.45 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 1.31M | 795K | 19K | 1.56M | 2.31M |
| Total Non-Current Assets | 1.71M | 1.06M | 36.78M | 26.2M | 34.1M | 24.98M | 61.16M | 43.82M |
| Property, Plant & Equipment | 1.64M | 965K | 1.77M | 3.06M | 3.18M | 1.85M | 1.15M | 1.1M |
| Fixed Asset Turnover | 0.02x | 0.03x | 0.05x | 0.09x | 0.10x | 0.04x | 0.07x | 0.05x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 1.03M | 910K | 881K |
| Long-Term Investments | 0 | 0 | 34.85M | 21.33M | 30.84M | 21.97M | 0 | 184.01M |
| Other Non-Current Assets | 72K | 98K | 157K | 1.82M | 77K | 124K | 59.1M | 47.07M |
| Total Assets | 23.26M▲ 0% | 14.8M▼ 36.4% | 147.03M▲ 893.7% | 116.33M▼ 20.9% | 95.44M▼ 18.0% | 72.58M▼ 24.0% | 101.93M▲ 40.5% | 93.54M▲ 0% |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | - | -36.39% | 893.71% | -20.88% | -17.96% | -23.96% | 40.45% | 88.25% |
| Total Current Liabilities | 5.9M | 11.24M | 8.41M | 15.54M | 24.44M | 24.77M | 24.19M | 23.42M |
| Accounts Payable | 748K | 441K | 1.2M | 1.55M | 1.05M | 1.97M | 862K | 767K |
| Days Payables Outstanding | 15.17K | 14.63K | 11.81K | 2.93K | 1.82K | 8.76K | 1.92K | 2.05K |
| Short-Term Debt | 3.67M | 8.03M | 0 | 0 | 0 | 0 | 2K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 3.12M | 9.08M | 20.23M | 0 | 20.32M | 60.94M |
| Other Current Liabilities | 294K | 321K | 3.56M | 1.07M | 926K | 20.52M | 3.01M | 2.34M |
| Current Ratio | 3.65x | 1.22x | 13.11x | 5.80x | 2.51x | 1.92x | 1.69x | 1.69x |
| Quick Ratio | 3.65x | 1.22x | 13.11x | 5.80x | 2.51x | 1.92x | 1.69x | 1.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | -1.96K |
| Total Non-Current Liabilities | 6.4M | 614K | 54K | 1.85M | 840K | 2K | 2.34M | 2.5M |
| Long-Term Debt | 5.44M | 348K | 0 | 0 | 0 | 0 | 0 | 2.5M |
| Capital Lease Obligations | 134K | 127K | 54K | 1.85M | 840K | 2K | 2.34M | 2.44M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 823K | 139K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.3M | 11.86M | 8.46M | 17.39M | 25.28M | 24.77M | 26.52M | 25.92M |
| Total Debt | 9.31M | 8.57M | 128K | 2.83M | 1.86M | 840K | 2.34M | 2.5M |
| Net Debt | -12.07M | -4.96M | -58.8M | -27.05M | -2.02M | -3.2M | -1.6M | -1.67M |
| Debt / Equity | 0.85x | 2.92x | 0.00x | 0.03x | 0.03x | 0.02x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | -0.07x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | 0.05x |
| Interest Coverage | -7.38x | -9.79x | -45.93x | -723.36x | -657.95x | -1173.93x | -4056.00x | -12560.33x |
| Total Equity | 10.96M▲ 0% | 2.94M▼ 73.2% | 138.56M▲ 4613.1% | 98.94M▼ 28.6% | 70.16M▼ 29.1% | 47.8M▼ 31.9% | 75.41M▲ 57.7% | 67.62M▲ 0% |
| Equity Growth % | - | -73.17% | 4613.06% | -28.59% | -29.09% | -31.86% | 57.75% | 127.12% |
| Book Value per Share | 0.61 | 0.16 | 4.50 | 3.20 | 2.25 | 1.44 | 1.58 | 1.35 |
| Total Shareholders' Equity | 10.96M | 2.94M | 138.56M | 98.94M | 70.16M | 47.8M | 75.41M | 67.62M |
| Common Stock | 0 | 0 | 3K | 3K | 3K | 3K | 4K | 4K |
| Retained Earnings | -111.61M | -131.46M | -166.47M | -210.65M | -246.9M | -279.79M | -311.72M | -320.12M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | -183K | -981K | -15K | 60K | 262K | 16K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SERA Cash Flow Statement
Sera Prognostics, Inc. (SERA) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -19.32M | -16.87M | -31.64M | -34.61M | -27.19M | -14.19M | -25.62M | -25.62M |
| Operating CF Margin % | -53677.78% | -67472% | -38580.49% | -12914.18% | -8884.97% | -18427.27% | -31633.33% | - |
| Operating CF Growth % | - | 12.71% | -87.55% | -9.4% | 21.44% | 47.81% | -80.58% | 1.15% |
| Net Income | -16.52M | -19.85M | -35.01M | -44.19M | -36.24M | -32.9M | -31.93M | -32.14M |
| Depreciation & Amortization | 946K | 895K | 659K | 756K | 900K | 833K | 940K | 917K |
| Stock-Based Compensation | 438K | 726K | 3.13M | 5.05M | 5.27M | 7.01M | 5.11M | 4.45M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -541K | 1.67M | -372K | 213K | -638K | -412K | 801K | -761K |
| Working Capital Changes | -3.65M | -311K | -44K | 3.55M | 3.52M | 11.28M | -546K | 688K |
| Change in Receivables | 6K | -2K | -3.14M | -2.97M | -5.36M | 11.42M | 22K | 14K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -534K | -307K | 603K | 352K | -442K | 455K | -1.01M | -83K |
| Cash from Investing | -6K | -149K | -82.56M | 5.55M | 438K | 11.74M | -28.5M | 25.29M |
| Capital Expenditures | -109K | -149K | -1.3M | -791K | -128K | -56K | -726K | -731K |
| CapEx % of Revenue | 302.78% | 596% | 1590.24% | 295.15% | 41.83% | 72.73% | 896.3% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 103K | 0 | 0 | 16K | 311K | -1.04M | 0 | 0 |
| Cash from Financing | 33.05M | 9.16M | 159.59M | 5K | 752K | 2.61M | 54.03M | 504K |
| Debt Issued (Net) | 2.98M | -1.7M | -7.66M | -303K | -466K | -440K | -194K | -79K |
| Equity Issued (Net) | 30.05M | 10.69M | 165.59M | 0 | 0 | 0 | 54.22M | 94K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 15K | 176K | 1.66M | 308K | 1.22M | 3.05M | 0 | 489K |
| Net Change in Cash | 13.72M▲ 0% | -7.86M▼ 157.3% | 45.4M▲ 677.8% | -29.05M▼ 164.0% | -26M▲ 10.5% | 163K▲ 100.6% | -99K▼ 160.7% | -1.05M▲ 0% |
| Free Cash Flow | -19.43M▲ 0% | -17.02M▲ 12.4% | -32.94M▼ 93.6% | -35.4M▼ 7.5% | -27.32M▲ 22.8% | -15.29M▲ 44.0% | -26.35M▼ 72.3% | -27.57M▲ 0% |
| FCF Margin % | -53980.56% | -68068% | -40170.73% | -13209.33% | -8926.8% | -19857.14% | -32529.63% | -48377.19% |
| FCF Growth % | - | 12.43% | -93.57% | -7.47% | 22.84% | 44.03% | -72.33% | -1.65% |
| FCF per Share | -1.07 | -0.94 | -1.07 | -1.14 | -0.88 | -0.46 | -0.55 | -0.55 |
| FCF Conversion (FCF/Net Income) | 1.17x | 0.85x | 0.90x | 0.78x | 0.75x | 0.43x | 0.80x | 0.86x |
| Interest Paid | 463K | 250K | 1.19M | 48K | 55K | 28K | 0 | 3K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SERA Key Ratios
Sera Prognostics, Inc. (SERA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -285.66% | -49.48% | -37.21% | -42.86% | -55.78% | -51.83% | -41.02% |
| Return on Invested Capital (ROIC) | - | -68.29% | -45.15% | -42.66% | -48.74% | -46.25% | -46.25% |
| Gross Margin | 56% | 54.88% | 27.99% | 31.37% | -6.49% | -102.47% | -191.23% |
| Net Margin | -79392% | -42693.9% | -16487.31% | -11843.79% | -42724.68% | -39417.28% | -56385.96% |
| Debt / Equity | 2.92x | 0.00x | 0.03x | 0.03x | 0.02x | 0.03x | 0.03x |
| Interest Coverage | -9.79x | -45.93x | -723.36x | -657.95x | -1173.93x | -4056.00x | -12560.33x |
| FCF Conversion | 0.85x | 0.90x | 0.78x | 0.75x | 0.43x | 0.80x | 0.86x |
| Revenue Growth | -30.56% | 228% | 226.83% | 14.18% | -74.84% | 5.19% | -50.43% |
SERA SEC Filings & Documents
Sera Prognostics, Inc. (SERA) SEC filings — annual & quarterly reports (10-K, 10-Q)
SERA Frequently Asked Questions
Sera Prognostics, Inc. (SERA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Sera Prognostics, Inc. (SERA) reported $0.1M in revenue for fiscal year 2025. This represents a 58% increase from $0.0M in 2019.
Sera Prognostics, Inc. (SERA) grew revenue by 5.2% over the past year. This is steady growth.
Sera Prognostics, Inc. (SERA) reported a net loss of $32.1M for fiscal year 2025.
Dividend & Returns
Sera Prognostics, Inc. (SERA) has a return on equity (ROE) of -51.8%. Negative ROE indicates the company is unprofitable.
Sera Prognostics, Inc. (SERA) had negative free cash flow of $27.6M in fiscal year 2025, likely due to heavy capital investments.
Explore More SERA
Sera Prognostics, Inc. (SERA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates